Higher Law: FDA Routes 'New Regulatory Pathway for CBD' Through Congress

“We do not intend to pursue rulemaking allowing the use of CBD in dietary supplements or conventional foods,” FDA principal deputy commissioner Janet Woodcock said Friday.

       
News
Author: News

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *